Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 101–125 of 566 matching trials (filtered from 7,816) · page 5 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Just-in-Time Coping Prompts for Reactive Digital Behavior in College Students NCT07789314 Momentary coping prompt; Active control message Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 80 | University of Florida OTHER |
2026-08-27 |
|
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) NCT06585787 KarXT; Placebo Runs in: Argentina; Belgium; Brazil; Bulgaria; China; Croatia; Fra... · 293 sites |
PHASE3 other |
RECRUITING | 406 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company INDUSTRY |
2026-08-26 |
|
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia NCT06651567 ITI-1284; Placebo Runs in: Bulgaria; Croatia; Czechia; Romania; Serbia; Slovakia; Sp... · 70 sites |
PHASE2 other |
RECRUITING | 320 | Intra-Cellular Therapies, Inc. INDUSTRY |
2026-08-26 |
|
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004) NCT07033494 MK-2214; Placebo Runs in: Argentina; Australia; Belgium; Canada; Japan; Netherlands... · 80 sites |
PHASE2 other |
RECRUITING | 340 | Merck Sharp & Dohme LLC INDUSTRY |
2026-08-26 |
|
A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease NCT07787182 LY4405094; LY4405094; Placebo; Placebo; Florbetapir F18; Florbetaben F 18 Runs in: United States · 10 sites |
PHASE1 other |
NOT_YET_RECRUITING | 68 | Eli Lilly and Company INDUSTRY |
2026-08-26 |
|
The Impact of Music Intervention on Sleep NCT06088810 CoMPoSER intervention group; Sleep Education Runs in: United States · 1 site |
NA other |
RECRUITING | 144 | Duke University OTHER |
2026-08-25 |
|
MCI Speech in Noise NCT06102486 Runs in: United States · 1 site |
NA other |
RECRUITING | 70 | Dartmouth-Hitchcock Medical Center OTHER |
2026-08-25 |
|
AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults NCT07701668 AI-based conversational intervention Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 80 | Massachusetts General Hospital OTHER |
2026-08-25 |
|
Restoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in Alzheimer's Disease NCT07756294 Empagliflozin; Insulin; Insulin Placebo; Empagliflozin Placebo Runs in: United States · 1 site |
PHASE2 other |
NOT_YET_RECRUITING | 30 | Wake Forest University Health Sciences OTHER |
2026-08-25 |
|
Mindfulness-Based Cognitive Therapy Vs. the Health Enhancement Program for Chronic Pain and Early Cognitive Decline; The Feeling of Being Pilot RCT NCT07785648 Feeling of Being; Health Enhancement Program Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 60 | Massachusetts General Hospital OTHER |
2026-08-25 |
|
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease NCT06297590 LY3954068; Placebo; Flortaucipir F18 Runs in: Japan; United Kingdom; United States · 10 sites |
PHASE1 other |
RECRUITING | 48 | Eli Lilly and Company INDUSTRY |
2026-08-24 |
|
Enhancing Attention and Wellbeing Using Digital Therapeutics NCT06397469 MediTrain; Worder Runs in: United States · 1 site |
NA other |
RECRUITING | 4,000 | University of California, San Francisco OTHER |
2026-08-24 |
|
2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients NCT06432166 2-hydroxybenzylamine acetate; Placebo Runs in: United States · 1 site |
PHASE1|PHASE2 other |
NOT_YET_RECRUITING | 48 | MTI Biotech Inc INDUSTRY |
2026-08-24 |
|
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis NCT07029581 ACP-204; Placebo Runs in: Bulgaria; Czechia; France; Italy; Serbia; United States · 60 sites |
PHASE2 other |
RECRUITING | 180 | ACADIA Pharmaceuticals Inc. INDUSTRY |
2026-08-24 |
|
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau NCT07142278 DUVAX 200 µg; DUVAX 400 µg; Placebo (Adjuvant only) Runs in: United States · 1 site |
PHASE1 other |
NOT_YET_RECRUITING | 24 | Nuravax, Inc. INDUSTRY |
2026-08-24 |
|
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease NCT07178210 Symani Surgical System Runs in: United States · 3 sites |
NA other |
RECRUITING | 15 | MMI (Medical Microinstruments, Inc.) INDUSTRY |
2026-08-24 |
|
AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) NCT07158905 AV-1980R 20 µg; AV-1980R 60 µg; AV-1980R 180 µg; Placebo Runs in: United States · 6 sites |
PHASE1 other |
RECRUITING | 48 | Institute for Molecular Medicine OTHER |
2026-08-21 |
|
Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease NCT07764185 Recharge Behavioral Therapy; Traditional Educational/Resources Program Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 150 | Photozig, Inc. INDUSTRY |
2026-08-21 |
|
VICA: A Virtual Care Assistant for Dementia Caregivers NCT07779785 VICA - Virtual Informal Care Assistant; Education only BPSD mobile app Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 120 | Indiana University OTHER |
2026-08-21 |
|
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration NCT07780383 BMS-986446 Runs in: United States · 1 site |
PHASE1 other |
NOT_YET_RECRUITING | 84 | Bristol-Myers Squibb INDUSTRY |
2026-08-21 |
|
A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD NCT05081596 PATH-Pain Runs in: United States · 1 site |
NA other |
RECRUITING | 100 | Weill Medical College of Cornell University OTHER |
2026-08-20 |
|
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes NCT05643144 Continuous Glucose Monitoring Runs in: United States · 1 site |
NA other |
RECRUITING | 62 | Indiana University OTHER |
2026-08-20 |
|
Center for Research and Education on Aging and Technology Enhancement - CREATE V - Project 1 NCT05811338 Project 1 - Phase 2: VR Program for Social, Activity, and Cognitive... Runs in: United States · 3 sites |
NA other |
NOT_YET_RECRUITING | 108 | Weill Medical College of Cornell University OTHER |
2026-08-20 |
|
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease NCT06976216 KarXT; KarX-EC; Placebo Runs in: Argentina; Australia; Brazil; Canada; Chile; Croatia; Cze... · 119 sites |
PHASE3 other |
RECRUITING | 586 | Bristol-Myers Squibb INDUSTRY |
2026-08-20 |
|
Technology-Based Intervention Pilot Testing NCT07146581 SIRENS Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 40 | Weill Medical College of Cornell University OTHER |
2026-08-20 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial